Long-term neurocognitive sequelae in pediatric medulloblastoma survivors treated according to the HIT protocol
- PMID: 40377898
- DOI: 10.1007/s11060-025-05070-5
Long-term neurocognitive sequelae in pediatric medulloblastoma survivors treated according to the HIT protocol
Abstract
Objective: Medulloblastoma is the most prevalent malignant brain tumour in children. Although contemporary comprehensive anticancer therapy has been shown to result in favourable survival and relapse outcomes, the long-term toxic effects on cognitive and motor function remain a concern. This study aims to investigate the long-term neurotoxic effects on cognitive function in paediatric medulloblastoma survivors.
Method: Data from 70 patients (Mage = 12.7 ± 2.94 years, 40% female) in remission treated according to the HIT protocol who underwent comprehensive neuropsychological assessment were analyzed. General linear models (GLMs) were constructed to assess the contribution of remission duration, chemotherapy type, and radiation dose to variability in cognitive performance on the CANTAB and DTKI tests.
Results: GLM revealed that remission > 4 years was associated with poorer processing speed, attention, and executive functions: cognitive flexibility, inhibitory control, planning, and working memory compared to participants with shorter remission. Induction therapy with methotrexate had more pronounced long-term negative effects on processing speed. However, no significant effects were observed across different radiation doses.
Conclusions: Remission duration emerged as a more significant predictor of a poor neurocognitive outcome than chemotherapy type or radiation dose, that is, the longer the remission, the more pronounced the neurocognitive impairment becomes. This highlights the need for continued monitoring and the development of targeted rehabilitation interventions for paediatric medulloblastoma survivors.
Keywords: HIT; Long-term effects; Medulloblastoma; Neurotoxicity; Pediatric brain tumour survivors.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology (protocol number 8/2017 of 24.10.2017). Information about the trial was provided to participants and their parents/legal representatives. Written informed consent was obtained from all participants or their parents/legal representatives. Précis: This study suggests that pediatric medulloblastoma patients treated with the HIT protocol experience cognitive decline that worsens after the completion of active treatment. Longer duration of remission is associated with poorer scores on cognitive tests which underscores the importance of continuous monitoring and targeted rehabilitative interventions for medulloblastoma survivors. Competing interests: The authors declare no competing interests.
Similar articles
-
Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades.Neuro Oncol. 2025 Jan 12;27(1):254-266. doi: 10.1093/neuonc/noae119. Neuro Oncol. 2025. PMID: 38963825 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Nutritional interventions for survivors of childhood cancer.Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2. Cochrane Database Syst Rev. 2016. PMID: 27545902 Free PMC article.
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
A systematic overview of chemotherapy effects in acute myeloid leukaemia.Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321. Acta Oncol. 2001. PMID: 11441935
References
-
- Mahapatra S, Amsbaugh MJ (2025) Medulloblastoma. In: StatPearls. StatPearls Publishing, Treasure Island (FL)
-
- Hanzlik E, Woodrome SE, Abdel-Baki M et al (2015) A systematic review of neuropsychological outcomes following posterior fossa tumor surgery in children. Childs Nerv Syst 31:1869–1875. https://doi.org/10.1007/s00381-015-2867-3 - DOI - PubMed
-
- Saury J-MG, Emanuelson I (2011) Cognitive consequences of the treatment of Medulloblastoma among children. Pediatr Neurol 44:21–30. https://doi.org/10.1016/j.pediatrneurol.2010.07.004 - DOI - PubMed
-
- Schmahmann JD (2022) The cerebellar cognitive affective syndrome and the neuropsychiatry of the cerebellum. In: Manto MU, Gruol DL, Schmahmann JD et al (eds) Handbook of the cerebellum and cerebellar disorders. Springer International Publishing, Cham, pp 1955–1993 - DOI
-
- Schreiber JE, Palmer SL, Conklin HM et al (2017) Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for Medulloblastoma on a multi-institutional, prospective study. Neuro-Oncol 19:1673–1682. https://doi.org/10.1093/neuonc/nox135 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical